Brookshire Cypress Jersey Village Katy
1.9K Reviews    |    4.7 Star Rating    |    20+ years of experience    |    75k+ Patients Treated
Call

Solitary Rectal Ulcer Syndrome Patient Journey

How do clinicians confirm SRUS, identify the defecation or prolapse mechanism that keeps injuring the rectum, and choose treatment that addresses both the lesion and its cause?

Jonathan’s path from bright-red rectal bleeding, mucus, prolonged straining, tenesmus, and a persistent sense of incomplete emptying to ulcerative SRUS with pelvic-floor dyssynergia, targeted treatment, and documented follow-up

Medically reviewed by: Dr. Bharat Pothuri, MD, FACG Specialty: Gastroenterology & Hepatology Last updated: 2026-08-11

GastroDoxs GutGuardians™

Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.

Jonathan’s Story: Biopsy-confirmed ulcerative SRUS with dyssynergic defecation and no full-thickness rectal prolapse

A 37-year-old a high-school counselor looking for an explanation for bright-red rectal bleeding, mucus, prolonged straining, tenesmus, and a persistent sense of incomplete emptying

Jonathan was a high-school counselor whose workdays made it easy to postpone evaluation of bright-red rectal bleeding, mucus, prolonged straining, tenesmus, and a persistent sense of incomplete emptying.

The symptoms were initially treated as ordinary hemorrhoids or constipation, but the persistent pattern did not fully fit either explanation.

Flexible sigmoidoscopy showed a shallow anterior rectal ulcer. Biopsies demonstrated fibromuscular obliteration and thickening of the muscularis mucosae without dysplasia, cancer, or inflammatory bowel disease. Anorectal manometry and balloon-expulsion testing then confirmed dyssynergic defecation.

The final plan used toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback. Follow-up focused on both symptom control and removal of the force that had kept injuring the rectal lining.

The biopsy ruled out the diagnoses I feared, but retraining how I emptied my bowel was what allowed the tissue to heal.

The First Signs: How Jonathan’s SRUS Appeared

Jonathan first noticed bright-red rectal bleeding and assumed a common anorectal problem would settle on its own.

Mucus, repeated urges, or incomplete evacuation made each bowel movement longer and more frustrating.

Extra straining briefly felt productive, but it increased friction and pressure against already injured rectal mucosa.

Persistent or changing bleeding prompted endoscopic examination rather than another round of symptom-only treatment.

When Jonathan Understood Why the Rectal Lesion Was Not Healing

The turning point was learning that ulcer treatment alone could not succeed while abnormal evacuation or prolapse continued to traumatize the same tissue.

Jonathan had worried that persistent bleeding meant cancer, especially after the lesion was seen on endoscopy.

Biopsy provided essential reassurance but also showed a specific mucosal-prolapse injury pattern rather than a nonspecific sore.

Function and anatomy testing connected that tissue pattern with ulcerative SRUS with pelvic-floor dyssynergia.

The team explained that symptom suppression could help, but sustainable healing required a lower-pressure, less traumatic way to evacuate or correction of clinically important prolapse.

That explanation made toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback feel like one coherent plan rather than unrelated recommendations.

Fear Was Replaced With Evidence

Representative biopsy addressed the cancer concern.

The Mechanism Became Visible

Testing demonstrated ulcerative SRUS with pelvic-floor dyssynergia.

Treatment Had a Defined Target

Each intervention addressed bleeding, stool passage, pelvic-floor coordination, or prolapse.

Why Jonathan Needed More Than Hemorrhoid or Constipation Treatment

Persistent rectal bleeding plus difficult evacuation required a coordinated assessment of tissue, function, anatomy, and prior treatment response.

The Bleeding Persisted

A changing or recurrent bleeding pattern required direct examination rather than indefinite empiric treatment.

The Lesion Needed Histology

Endoscopic appearance alone could not reliably distinguish SRUS from neoplasia or inflammatory disease.

Bowel Mechanics Were Abnormal

The history and testing pointed to ulcerative SRUS with pelvic-floor dyssynergia.

The Plan Needed an Endpoint

The team defined which symptom, laboratory, functional, or endoscopic changes would count as improvement.

Persistent Rectal Bleeding Deserves Tissue Diagnosis and a Bowel-Function Review

GastroDoxs can review rectal bleeding, mucus, endoscopy, biopsy, constipation, outlet dysfunction, prolapse symptoms, pelvic-floor testing, and prior treatment.

How Jonathan’s Symptoms Led to a Cause-Directed Plan

The sequence moved from a nonspecific bleeding complaint to tissue diagnosis, bowel-function assessment, mechanism-specific treatment, and measured follow-up.

Bleeding or Mucus Persists

Jonathan tracked the frequency, color, volume, stool relationship, and associated pain instead of assuming every episode came from hemorrhoids.

Review rectal bleeding →

Endoscopy Finds a Rectal Lesion

The rectum and relevant colon were examined, and suspicious or atypical tissue was sampled.

Review colonoscopy →

Biopsy Establishes Mucosal-Prolapse Injury

Pathology supported SRUS while excluding neoplasia and other inflammatory or infectious patterns.

Review SRUS →

Testing Reveals the Driver

The key mechanism was ulcerative SRUS with pelvic-floor dyssynergia, which changed the treatment from lesion-only therapy to cause-directed management.

Schedule evaluation →

Decisions That Shaped Jonathan’s SRUS Evaluation

A credible SRUS diagnosis must explain the rectal lesion, exclude dangerous mimics, and identify the mechanical or behavioral process that prevents healing.

Confirm the Source of Bleeding

The team determined whether Jonathan’s bleeding came from the visible rectal lesion or another anorectal or colonic source.

Obtain Representative Tissue

Biopsy was deep enough to evaluate mucosal-prolapse histology and exclude dysplasia, cancer, inflammatory bowel disease, infection, and other ulcer causes.

Measure Evacuation Function

Testing was selected from digital rectal examination, flexible sigmoidoscopy with biopsy, anorectal manometry, and balloon-expulsion testing to define the process behind repeated injury.

Match Treatment to Mechanism

The working plan used toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback rather than treating the endoscopic appearance alone.

Document Response

Symptoms, bowel mechanics, hemoglobin when relevant, and repeat endoscopy when clinically indicated were used to judge whether healing was occurring.

Rectal bleeding should not be attributed to SRUS until the lesion is examined and appropriately sampled. A prior SRUS label does not rule out a new or separate bleeding source.

How Clinicians Interpreted Jonathan’s Biopsy-confirmed ulcerative SRUS with dyssynergic defecation and no full-thickness rectal prolapse

SRUS is interpreted by aligning symptoms, lesion morphology, biopsy findings, evacuation behavior, pelvic-floor function, prolapse anatomy, and treatment response.

SRUS Belongs to the Mucosal-Prolapse Spectrum

Repeated traction, compression, ischemia, and direct trauma can create the characteristic rectal injury.

Location and Shape Are Helpful but Not Definitive

Lesions often occur on the anterior rectal wall, but distance, number, shape, and surface appearance vary.

Biopsy Must Fit the Clinical Picture

Fibromuscular obliteration and muscularis mucosae abnormalities support the diagnosis but still require clinicopathologic correlation.

Defecatory Disorders Are Common Treatment Targets

Paradoxical contraction, inadequate propulsion, prolonged straining, and incomplete evacuation can perpetuate mucosal injury.

Dyssynergia Without Full-Thickness Prolapse

In this composite, flexible sigmoidoscopy showed a shallow anterior rectal ulcer. Biopsies demonstrated fibromuscular obliteration and thickening of the muscularis mucosae without dysplasia, cancer, or inflammatory bowel disease. Anorectal manometry and balloon-expulsion testing then confirmed dyssynergic defecation.

What Happened During Jonathan’s Evaluation

The visit converted a sensitive symptom history and a concerning rectal lesion into a diagnosis, a mechanism, and a measurable treatment plan.

Bleeding and Safety Review

The clinician assessed bleeding amount, anemia symptoms, pain, fever, bowel obstruction, weight change, family history, and medication effects.

Detailed Evacuation History

Stool form, frequency, straining duration, toilet time, manual maneuvers, prolapse, urgency, mucus, and incomplete emptying were documented.

Anorectal and Endoscopic Correlation

Examination and endoscopic images were compared with lesion location, morphology, and biopsy sampling.

Targeted Function or Anatomy Testing

The selected workup included digital rectal examination, flexible sigmoidoscopy with biopsy, anorectal manometry, and balloon-expulsion testing.

Shared Treatment Choice

The team explained why toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback best matched the identified driver and what would trigger escalation.

From Ulcerative SRUS with pelvic-floor dyssynergia to a Lower-Trauma Bowel Plan

Treatment follows a step-up approach: remove repetitive trauma, normalize stool passage, retrain evacuation when indicated, use lesion-directed therapy selectively, and correct significant prolapse when conservative care cannot succeed.

Limit Straining and Toilet Time

Short, unforced toilet sessions reduce repeated pressure and shearing against the rectal lining.

Optimize Stool Consistency

Fiber, fluid, osmotic agents, or other clinician-guided measures are individualized because both hard stool and frequent loose stool can aggravate symptoms.

Stop Direct Rectal Trauma

Digital evacuation, repeated suppository insertion, or other injurious maneuvers are replaced with safer evacuation strategies.

Use Pelvic-Floor Biofeedback When Indicated

Biofeedback retrains propulsion, anal relaxation, sensory awareness, and efficient evacuation in patients with a documented or strongly suspected defecatory disorder.

Use Lesion-Directed Therapy Selectively

Topical sucralfate, mesalamine, corticosteroids, or endoscopic hemostatic therapy may be considered for selected patients, but supporting evidence is limited and the mechanical driver still matters.

Escalate for Important Prolapse or Refractory Disease

For this pattern, the plan centered on toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback; colorectal-surgery involvement depended on anatomy and response.

Why GI, Pathology, Pelvic-Floor, and Colorectal Coordination Matters

SRUS spans tissue diagnosis, bowel function, and prolapse anatomy. Coordination prevents a benign biopsy from ending the evaluation before the cause is understood.

Gastroenterology

Confirms the bleeding source, examines the rectum and colon as indicated, and coordinates lesion-directed treatment.

GI Pathology

Distinguishes mucosal-prolapse injury from cancer, inflammatory bowel disease, infection, ischemia, and other mimics.

Pelvic-Floor Therapy

Uses biofeedback when disordered evacuation and excessive straining contribute to ongoing injury.

Colorectal Surgery

Evaluates full-thickness prolapse or significant refractory internal prolapse when anatomy requires correction.

Preparing for an SRUS Consultation

A complete consultation connects the rectal lesion with bowel function and defines which findings require pelvic-floor, radiology, or colorectal-surgery coordination.

Endoscopy

Bring the full report, images, lesion location, bowel-preparation quality, and prior treatment.

Pathology

Bring the report and information needed to obtain slides when the diagnosis remains uncertain.

Bowel Function

Bring a stool and symptom log that includes straining, toilet time, incomplete evacuation, mucus, bleeding, and manual maneuvers.

Prior Testing

Bring blood counts, defecography, manometry, balloon-expulsion results, pelvic-floor notes, and surgical consultations.

Planning SRUS Evaluation and Follow-Up

Coverage can differ for consultation, sigmoidoscopy or colonoscopy, biopsy and pathology review, anorectal manometry, balloon-expulsion testing, defecography, pelvic-floor biofeedback, endoscopic treatment, and colorectal surgery.

Confirm the Diagnostic Service

Ask whether the planned test is office-based, hospital-based, radiology-based, or performed by a pelvic-floor center.

Verify Pathology Review

Outside-slide review may be billed separately from the endoscopy that produced the specimen.

Check Pelvic-Floor Benefits

Biofeedback coverage may depend on diagnosis, referral, provider type, session limits, and prior authorization.

Send Records Before Scheduling Procedures

Prior images, histology, blood counts, and function tests can prevent unnecessary repetition and clarify the correct next service.

Why Jonathan Chose the Final SRUS Strategy

The selected plan matched symptom severity, biopsy certainty, evacuation physiology, prolapse anatomy, prior treatment, and the risk of continued rectal trauma.

The Diagnosis Was Secure

Representative tissue supported SRUS and did not show dysplasia or malignancy.

The Driver Was Identified

The evidence pointed to ulcerative SRUS with pelvic-floor dyssynergia.

The Least Invasive Effective Option Came First

The initial or supporting plan used toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback.

Escalation Criteria Were Explicit

Persistent heavy bleeding, anemia, nonhealing disease, important prolapse, or failure of well-delivered conservative care would trigger reassessment.

SRUS Treatment Pathways

The correct pathway depends on the mechanism sustaining injury, not merely the size or appearance of the rectal lesion.

Bowel-Habit and Stool Optimization

Reduce straining, shorten toilet time, stop digital trauma, and individualize stool consistency.

Best for: Mild disease or a reversible behavioral driver

Limitations: May be insufficient when dyssynergia or significant prolapse persists

Takeaway: Foundational for nearly every plan

Pelvic-Floor Biofeedback

Retrain rectoanal coordination, propulsion, relaxation, and more efficient evacuation.

Best for: Dyssynergic defecation or excessive straining

Limitations: Requires access, participation, and practice; it cannot repair every prolapse

Takeaway: Treat the functional driver

Topical or Endoscopic Therapy

Use selected topical anti-inflammatory or barrier therapy, or endoscopic hemostasis for a defined bleeding problem.

Best for: Persistent symptoms or bleeding in carefully selected cases

Limitations: Evidence is limited, recurrence is possible, and mechanics still need treatment

Takeaway: Adjunct rather than universal cure

Prolapse-Directed Surgery

Correct full-thickness prolapse or selected refractory internal prolapse using an individualized colorectal operation.

Best for: Anatomic prolapse that prevents healing or causes major symptoms

Limitations: Operative risks, recurrence, and postoperative bowel-function changes require discussion

Takeaway: Repair the anatomy when conservative care cannot

When Rectal Symptoms Need Prompt or Emergency Care

SRUS is benign, but severe bleeding, obstruction, infection, ischemic prolapse, or a different diagnosis can create urgent risk.

Heavy, continuous, or rapidly increasing rectal bleeding
Fainting, confusion, chest pain, shortness of breath, or severe weakness with bleeding
Black tarry stool or vomiting blood, which suggests a source beyond typical SRUS
A prolapsed rectal segment that cannot be gently returned or becomes dark, very painful, or markedly swollen
Severe or rapidly worsening abdominal, pelvic, anal, or rectal pain
Fever, shaking chills, pus-like drainage, or rapidly worsening illness
Persistent vomiting or inability to keep liquids down
Inability to pass stool or gas with increasing abdominal distension
Rapid unintentional weight loss, worsening anemia, or progressive fatigue
A new rectal mass, changing stool caliber, or bleeding pattern that has not been evaluated

Jonathan’s Life With a Mechanism-Based SRUS Plan

How treatment for ulcerative SRUS with pelvic-floor dyssynergia changed symptoms, evacuation, and follow-up

Bleeding became occasional, mucus and tenesmus receded, bowel movements required less effort, and follow-up endoscopy showed substantial ulcer healing.

The result followed toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback, with each component linked to a specific source of pressure, trauma, bleeding, or prolapse.

Follow-up did not rely on pain alone; bleeding frequency, mucus, toilet time, evacuation effort, anemia when relevant, and endoscopic findings were considered together.

Jonathan understood that recurrence would prompt reassessment of bowel mechanics and anatomy rather than indefinite self-treatment.

The plan also preserved a clear safety boundary for heavy bleeding, severe pain, obstructive symptoms, fever, or a trapped prolapse.

The biopsy ruled out the diagnoses I feared, but retraining how I emptied my bowel was what allowed the tissue to heal.
Educational Disclaimer

This educational composite illustrates biopsy-confirmed ulcerative SRUS with dyssynergic defecation and no full-thickness rectal prolapse. It does not represent a specific patient or promise a result. SRUS can resemble cancer, inflammatory bowel disease, infection, ischemia, and other rectal disorders, so diagnosis requires appropriate examination and biopsy. Treatment may include bowel-habit change, stool regulation, pelvic-floor biofeedback, selected topical or endoscopic therapy, and prolapse-directed surgery. Heavy bleeding, fainting, severe pain, fever, obstruction, or an incarcerated prolapse requires prompt assessment.

Solitary Rectal Ulcer Syndrome FAQs

Answers about symptoms, biopsy, cancer exclusion, pelvic-floor testing, biofeedback, topical therapy, prolapse surgery, follow-up, office access, and urgent bleeding

Solitary rectal ulcer syndrome, or SRUS, is a benign mucosal-prolapse disorder in which repeated straining, abnormal pelvic-floor coordination, internal prolapse, or direct trauma can injure the rectal lining.

No. The name can be misleading. Examination may show one ulcer, several ulcers, redness, flat erosions, or a polypoid lesion, and some biopsy-confirmed cases have no classic open ulcer.

Common symptoms include bright-red rectal bleeding, mucus, tenesmus, rectal pain, prolonged straining, constipation, repeated bathroom visits, incomplete evacuation, and sometimes a prolapse sensation.

Yes. An ulcerated or polypoid lesion can resemble rectal cancer, inflammatory bowel disease, or another disorder. Adequate biopsy and pathology correlation are essential before the label SRUS is accepted.

Diagnosis combines symptoms, anorectal examination, sigmoidoscopy or colonoscopy, and biopsy. Defecography, anorectal manometry, and balloon-expulsion testing may identify internal prolapse or dyssynergic defecation.

Typical findings include fibromuscular obliteration of the lamina propria, thickening or extension of the muscularis mucosae, crypt distortion, and surface erosion. A pathologist also checks for dysplasia, cancer, and inflammatory disease.

Pelvic-floor biofeedback can help when straining or dyssynergic defecation sustains the injury. It teaches coordinated relaxation and more effective evacuation, but response depends on the underlying anatomy and adherence.

Sucralfate, mesalamine, or corticosteroid preparations are sometimes used, but evidence is limited and they do not correct prolapse, dyssynergia, or repeated trauma. Treatment must address the mechanical driver.

Surgery is generally reserved for full-thickness rectal prolapse, significant internal prolapse with refractory symptoms, or persistent disease despite well-delivered conservative and pelvic-floor treatment.

Seek urgent care for heavy or continuous bleeding, fainting, chest pain, shortness of breath, severe weakness, black stool, severe abdominal or rectal pain, fever, or inability to pass stool and gas.

GastroDoxs GutHero Quest™

  1. 1

    Identify the Bleeding Source

    Separate SRUS from hemorrhoids, fissure, neoplasia, inflammatory disease, infection, ischemia, and other causes.

  2. 2

    Confirm the Tissue Pattern

    Use representative biopsy and clinicopathologic correlation rather than endoscopic appearance alone.

  3. 3

    Map Bowel Function and Prolapse

    Use history, examination, and selected testing to define ulcerative SRUS with pelvic-floor dyssynergia and other treatment-changing mechanisms.

  4. 4

    Reduce Pressure and Direct Trauma

    Shorten toilet time, limit straining, optimize stool form, and stop injurious manual maneuvers.

  5. 5

    Retrain or Repair the Driver

    Apply toilet-time limits, avoidance of straining and digital evacuation, clinician-guided stool regulation, and pelvic-floor biofeedback according to the confirmed functional or anatomic problem.

  6. 6

    Measure Healing and Watch for Recurrence

    Track bleeding, mucus, evacuation effort, anemia when present, prolapse, and repeat endoscopic findings when clinically indicated.

Need a Solitary Rectal Ulcer Syndrome Review?

GastroDoxs can review rectal bleeding, mucus, endoscopy, biopsy, constipation, outlet dysfunction, prolapse symptoms, pelvic-floor testing, and previous treatment.